| Agitation |
0 |
0.74 |
| Bipolar Disorder |
0 |
0.7 |
| Food and Drug Administration (FDA) |
0 |
0.49 |
| Schizophrenia |
0 |
0.7 |
| Orthostatic Hypotension |
0 |
0.35 |
| Hypotension |
0 |
0.33 |
| Xerostomia |
0 |
0.12 |
| Adverse Effects |
0 |
0.08 |
| Bradycardia |
0 |
0.08 |
| Caregiver |
0 |
0.08 |
| Dizziness |
0 |
0.08 |
| Drug Reaction |
0 |
0.08 |
| Interprofessional Continuing Education |
0 |
0.08 |
| Mental Illness |
0 |
0.08 |
| Mouth |
0 |
0.08 |
| Paresthesia |
0 |
0.08 |
| Translational Research |
0 |
0.08 |
| Arrhythmia |
0 |
0.07 |
| Dentistry and Oral Health |
0 |
0.07 |
| Patient Safety |
0 |
0.07 |